Topics

NOXXON Announces Completion of €1 Million Capital Increase

02:01 EDT 15 Aug 2019 | FinanzNachrichten

Regulatory News: NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), repo...

Original Article: NOXXON Announces Completion of €1 Million Capital Increase

NEXT ARTICLE

More From BioPortfolio on "NOXXON Announces Completion of €1 Million Capital Increase"

Quick Search

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...